Opinion statement Cardiac masses and tumors are a heterogenous group of disorders and
include primary tumors (both benign and malignant), metastatic disease, and numerous …

Background Primary cardiac angiosarcoma (PCA) is the most prevalent histological type of
cardiac sarcoma but its rarity poses a challenge for standardizing treatment protocols …

Background Data on primary cardiac malignancies are limited to small single-center studies.
Objectives The aim of the current study was to provide detailed outcomes for treatment of …

Most surgeons will encounter only a handful of primary cardiac tumors outside of myxomas.
Approximately 3 quarters of primary cardiac tumors are benign and 1 quarter is malignant. In …

Objective We aim to evaluate the survival outcomes of primary cardiac sarcoma in a US
nationwide cancer database. Methods The Surveillance, Epidemiology, and End Results …

Introduction. Primary cardiac sarcoma (PCS) has a poor prognosis compared to other
sarcomas due to late presentation, challenging resection, incidence of metastases, and …

Objective This study aimed to understand the population-level treatment modalities and to
evaluate the survival benefits of surgical resection in primary cardiac lymphoma. Methods …

Angiosarcoma is an extremely rare and aggressive malignancy. Standard of care of
localized tumors includes surgery±radiation. Despite this multimodal treatment,> 50% of the …

Introduction: Primary cardiac tumors are exceedingly rare, with approximately 75%
representing benign lesions. Sarcoma represents the most common primary cardiac …

Objective Cardiac sarcoma represents a rare and aggressive form of cancer with a paucity of
data to produce outcome-driven evidence-based guidelines. Current surgical management …